Sridharan Gururangan

6PUBLICATIONS
62CO-AUTHORS
Oral medicine and pathologyInfant and child healthGene and molecular therapyPredictive and prognostic markersChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 20, 2021
Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry.

Margot A Lazow, Christine Fuller, Mariko DeWire

|Jan 27, 2021
Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma.

Rahul Kumar, Kyle S Smith, Maximilian Deng

|Jan 06, 2021
Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).

Amar Gajjar, Giles W Robinson, Kyle S Smith

|Aug 07, 2019
Acute neurotoxicity following vincristine due to Charcot-Marie-Tooth disease in a young child with medulloblastoma.

Trisha Kissoon, Sridharan Gururangan, John Sladky

|Aug 22, 2017
Regulatory T cell subsets in patients with medulloblastoma at diagnosis and during standard irradiation and chemotherapy (PBTC N-11).

Sridharan Gururangan, Elizabeth Reap, Robert Schmittling

Pageof 1